Blood Cancer Studies Assess Genetics, Modified Treatment To Improve Outcomes, Reduce Toxicity


Research identifying genetic factors that affect survival of patients with blood cancers and evaluating the effectiveness of modified treatment strategies to improve outcomes while reducing toxicity were presented at the 54th Annual Meeting of the American Society of Hematology (ASH).

While the cancer research community has seen many significant therapeutic advances over the last decade, only recently have investigators identified how patients' individual genetic makeup influences their short- and long-term response to therapy, demonstrating that while the disease may respond positively to therapy, the patient may not. Current studies take these insights a step further, examining specific patient subpopulations to determine their risk for negative outcomes and whether early preventive interventions or treatment adjustments may help avoid treatment-related toxicity.

Read more 

Christine Bork
Email Christine
(800) 458-6223



Childhood Cancer

Medical Information

Research

Coping with Cancer

Get Involved

About Us